Clinical Trials · NCT00681187

Somatuline Autogel Preference and Health Economy Study

CompletedPhase 4Lanreotide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Ipsen
Enrollment
26
Start date
Jun 2008
Locations
10 sites, 3 countries
Primary endpoint
Subject Preference for Self or Partner Administration
View Lanreotide compound reference